Encompass More Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
682
+9
+1% +$3.08K 0.04% 241
2026
Q1
$237K Hold
673
0.04% 218
2025
Q4
$220K Buy
+673
New +$213K 0.04% 224
2025
Q3
Sell
-838
Closed -$234K 242
2025
Q2
$234K Sell
838
-120
-13% -$34K 0.05% 187
2025
Q1
$299K Sell
958
-460
-32% -$136K 0.09% 151
2024
Q4
$370K Buy
1,418
+76
+6% +$22.5K 0.12% 134
2024
Q3
$432K Buy
1,342
+162
+14% +$53K 0.16% 108
2024
Q2
$369K Sell
1,180
-265
-18% -$77.9K 0.26% 61
2024
Q1
$411K Buy
1,445
+526
+57% +$154K 0.34% 57
2023
Q4
$265K Buy
+919
New +$250K 0.3% 66

Other funds holding AMGN

Encompass More Asset Management's AMGN Position: Q2 2026 in Review

Encompass More Asset Management increased its Amgen (AMGN) stake by 1.3% in Q2 2026, buying an estimated $3.08K and bringing the position to 682 shares worth $247K. The position accounts for 0.04% of the portfolio, ranked #241.

Encompass More Asset Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $432K in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Encompass More Asset Management held 682 shares of Amgen worth $247K as of Q2 2026.
  • Encompass More Asset Management bought 9 Amgen shares in Q2 2026, an estimated $3.08K.
  • Amgen made up 0.04% of Encompass More Asset Management's portfolio in Q2 2026, its #241 holding.
  • Encompass More Asset Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Encompass More Asset Management's Amgen position peaked at $432K in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.